Tackling nonadherence in psychiatric disorders: current opinion

Nonadherence to treatment is a major challenge in all fields of medicine, and it has been claimed that increasing the effectiveness of adherence interventions may have far greater impact on the health of the population than any improvement in specific medical treatments. However, despite widespread use of terms such as adherence and compliance, there is little agreement on definitions or measurements. Nonadherence can be intermittent or continuous, voluntary or involuntary, and may be specific to single or multiple interventions, which makes reliable measurement problematic. Both direct and indirect methods of assessment have their limitations. The current literature focuses mainly on psychotic disorders. A large number of trials of various psychological, social, and pharmacologic interventions has been reported. The results are mixed, but interventions specifically designed to improve adherence with a more intensive and focused approach and interventions combining elements from different approaches such as cognitive-behavioral therapy, family-based, and community-based approaches have shown better outcomes. Pharmacologic interventions include careful drug selection, switching when a treatment is not working, dose adjustment, simplifying the treatment regimen, and the use of long-acting injections. The results for the most studied pharmacologic intervention, ie, long-acting injections, are far from clear, and there are discrepancies between randomized controlled trials, nationwide cohort studies, and mirror-image studies. Nonadherence with treatment is often paid far less attention in routine clinical practice and psychiatric training. Strategies to measure and improve adherence in clinical practice are based more on personal experience than on research evidence. This overview focuses on strategies used for improving treatment adherence in psychiatric disorders in the light of current evidence, with emphasis on public health aspects of treatment adherence and the management of nonadherence in routine clinical practice.

[1]  R. Haynes,et al.  Interventions for enhancing medication adherence. , 2008, The Cochrane database of systematic reviews.

[2]  A. Vita,et al.  Non-Pharmacological Strategies to Enhance Adherence and Continuity of Care in Schizophrenia , 2014 .

[3]  M. Mimura,et al.  Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. , 2014, Schizophrenia bulletin.

[4]  J. Rugkåsa,et al.  Community treatment orders: Current evidence and the implications , 2013, British Journal of Psychiatry.

[5]  A. Siracusano,et al.  Adherence to Antipsychotics in Schizophrenia , 2013 .

[6]  S. Farooq Public health and physician focused strategies to improve medication adherence in psychotic disorders , 2013, World psychiatry : official journal of the World Psychiatric Association.

[7]  Taishiro Kishimoto,et al.  Non‐adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies , 2013, World psychiatry : official journal of the World Psychiatric Association.

[8]  M. Torem Participatory Pharmacotherapy: 10 Strategies for Enhancing Adherence: Engaging Patients as Partners in Treatment Can Improve Outcomes , 2013 .

[9]  Roy H Perlis,et al.  First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. , 2013, The Journal of clinical psychiatry.

[10]  Stefan Priebe,et al.  Medical Decision Making Shared decision-making in ongoing outpatient psychiatric treatment , 2013 .

[11]  S. Priebe,et al.  Community treatment orders for patients with psychosis (OCTET): a randomised controlled trial , 2013, The Lancet.

[12]  S. Dye,et al.  Supervised community treatment: 2-year follow-up study in Suffolk , 2012 .

[13]  Laura Thompson,et al.  The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review , 2012, BMC Psychiatry.

[14]  P. Llorca,et al.  The influence of therapeutic alliance and insight on medication adherence in schizophrenia , 2012, Nordic journal of psychiatry.

[15]  M. Irfan,et al.  Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS) , 2011, British Journal of Psychiatry.

[16]  J. Tiihonen,et al.  A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. , 2011, The American journal of psychiatry.

[17]  R. Rosenheck,et al.  Long-acting risperidone and oral antipsychotics in unstable schizophrenia. , 2011, The New England journal of medicine.

[18]  Medication adherence and its relationship to the therapeutic alliance: Results from an innovative pilot study within a community pharmacy MTM practice , 2011 .

[19]  O. Andreassen,et al.  Medication Adherence in Outpatients With Severe Mental Disorders: Relation Between Self-Reports and Serum Level , 2010, Journal of clinical psychopharmacology.

[20]  S. Dabbo,et al.  Motivational Interviewing: Preparing People to Change Addictive Behavior , 1993 .

[21]  P. Weiden,et al.  The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. , 2009, The Journal of clinical psychiatry.

[22]  M. Valenstein,et al.  Dosing frequency and adherence to antipsychotic medications. , 2008, Psychiatric services.

[23]  Haynes Rb,et al.  Interventions for enhancing medication adherence (Review) , 2008 .

[24]  M. Leese,et al.  Staff and patient perspectives on unmet need and therapeutic alliance in community mental health services , 2007, British Journal of Psychiatry.

[25]  T. Lincoln,et al.  Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysis , 2007, Schizophrenia Research.

[26]  Alexander L. Miller,et al.  Relationships among subjective and objective measures of adherence to oral antipsychotic medications. , 2007, Psychiatric services.

[27]  A. David,et al.  Adherence therapy for people with schizophrenia , 2006, British Journal of Psychiatry.

[28]  M. Valenstein,et al.  Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. , 2006, The Journal of clinical psychiatry.

[29]  B. Mausbach,et al.  Functional Adaptation Skills Training (FAST): A randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders , 2006, Schizophrenia Research.

[30]  Marsha A Raebel,et al.  Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures , 2006, The Annals of pharmacotherapy.

[31]  J. Lefante,et al.  Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications , 2006, Current opinion in cardiology.

[32]  D. Penn,et al.  Do Baseline Client Characteristics Predict the Therapeutic Alliance in the Treatment of Schizophrenia? , 2006, The Journal of nervous and mental disease.

[33]  A. Lippman Adherence to medication. , 2005, The New England journal of medicine.

[34]  R B Haynes,et al.  Interventions to enhance medication adherence. , 2005, The Cochrane database of systematic reviews.

[35]  P. Weiden,et al.  Teaching Medication Compliance to Psychiatric Residents: Placing an Orphan Topic Into a Training Curriculum , 2005, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

[36]  Christian R. Dolder,et al.  Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. , 2004, The American journal of psychiatry.

[37]  G. Donohoe,et al.  Compliance therapy: a randomised controlled trial in schizophrenia , 2003, BMJ : British Medical Journal.

[38]  A. Peterson,et al.  Meta-analysis of trials of interventions to improve medication adherence. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[39]  L. Merinder,et al.  Psychoeducation for schizophrenia. , 2011, The Cochrane database of systematic reviews.

[40]  Mark Olfson,et al.  Interventions to improve medication adherence in schizophrenia. , 2002, The American journal of psychiatry.

[41]  Christian R. Dolder,et al.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.

[42]  L. Markson,et al.  Discontinuation of use and switching of antidepressants: influence of patient-physician communication. , 2002, JAMA.

[43]  Stephen Rollnick,et al.  Motivational Interviewing: Preparing People for Change, 2nd Edition , 2002 .

[44]  W. Katon,et al.  Collaborative Care Model to Improve Outcomes in Major Depression , 2002, The Annals of pharmacotherapy.

[45]  Jan Scott,et al.  Treatment non‐adherence in affective disorders , 2002, Acta psychiatrica Scandinavica.

[46]  M. Whooley,et al.  Managing depression in medical outpatients. , 2000, The New England journal of medicine.

[47]  N. Mcconaghy,et al.  Community Treatment Orders: Relationship to Clinical Care, Medication Compliance, Behavioural Disturbance and Readmission , 2000, The Australian and New Zealand journal of psychiatry.

[48]  J. Mintz,et al.  A program for relapse prevention in schizophrenia: a controlled study. , 2000, Archives of general psychiatry.

[49]  H. Wagner,et al.  Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals. , 1999, The American journal of psychiatry.

[50]  Cognitive and Behavioural Approaches to Medication Adherence , 1999 .

[51]  L. Merinder,et al.  Patient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness , 1999, Social Psychiatry and Psychiatric Epidemiology.

[52]  B. Mcfarland,et al.  Lithium use and discontinuation in a health maintenance organization. , 1996, The American journal of psychiatry.

[53]  R. Digiuseppe,et al.  Developing the therapeutic alliance in child—adolescent psychotherapy , 1996 .

[54]  P. Hayward,et al.  Compliance therapy in psychotic patients: randomised controlled trial , 1996, BMJ.

[55]  H. S. Davis,et al.  A Controlled Study , 1966 .